compound vs name brand tirzepatide COMPOUNDED Compounded Tirzepatide With B6 (Pyridoxine)

Current annual therapy cost: ~1.51.7 lakh per patient At 5060% lower pricing: ~70,00085,000 per year Savings of nearly 80,0001,00,000 per patient annually Now consider scale: 100,000 patients 75,000 750 crore annual market 500,000 patients (just ~0.5% of high-risk obese population) 3,750 crore opportunity And thats only drug revenue

Non-obese diabetic mice aged 7 weeks were treated for 1 week with JD-5037, then euthanised

This is the "Research Flywheel" in action: turning crowdsourced data into scientific breakthroughs, and then into tools that change lives

Obesity stigma and misconceptions Obesity is often misunderstood as solely a result of poor lifestyle choices, ignoring the genetic, hormonal, and environmental factors that contribute to it

My Easy Weight Loss offers Tirzepatide, a GLP-1 weight-loss medication

Learn how GLP-1 medicines like semaglutide may reduce visceral fat